EU and the US align policies on pharmaceuticals

EPA/JULIAN STRATENSCHULTE

A pharmacist takes a box of 'prescription only' Parkinson medicine out of a drawer in a pharmacy in Hanover, Germany, 19 October 2016. A leading judgement of the European Court of Justice stirs the German pharmacy market. The price fixing for prescription drugs supposedly limits the cross-border movement of goods and thus is against EU-law, the court in Luxemburg judged.

EU and the US align policies on pharmaceuticals


Share on Facebook
Share on Twitter
Share on Google+
Share on LinkedIn
+

The European Union and the United States delivered on a significant element of the Joint Statement agreed by Presidents Juncker and Trump in July 2018, that includes a commitment from both sides to reduce barriers and increase trade in a range of sectors, including pharmaceuticals.
This EU-U.S. Mutual Recognition Agreement is underpinned by robust evidence that the EU and the U.S. have comparable procedures to carry out good manufacturing practice inspections for human medicines, and will expand its scope to veterinary medicines, human vaccines and plasma derived medicinal products.

Share on Facebook
Share on Twitter
Share on Google+
Share on LinkedIn
+